BARCLAYS PLC - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 110 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$268
+143.6%
131,845
+175.3%
0.00%
Q2 2023$110
-37.1%
47,895
-16.8%
0.00%
Q1 2023$175
+146.5%
57,558
+88.7%
0.00%
Q4 2022$71
-99.2%
30,504
+566.2%
0.00%
Q3 2022$9,000
-40.0%
4,579
-15.5%
0.00%
Q2 2022$15,000
-98.5%
5,420
-98.4%
0.00%
-100.0%
Q1 2022$997,000
-52.7%
334,796
-38.3%
0.00%
Q4 2021$2,110,000
-22.6%
542,908
-14.6%
0.00%
-100.0%
Q3 2021$2,726,000
+8986.7%
635,456
+6310.3%
0.00%
Q2 2021$30,000
-91.2%
9,913
-90.4%
0.00%
Q1 2021$342,000
+34100.0%
102,869
+26209.2%
0.00%
Q4 2020$1,0000.0%391
+8.6%
0.00%
Q4 2019$1,000
-50.0%
360
-66.8%
0.00%
Q3 2019$2,000
-98.7%
1,083
-98.5%
0.00%
Q2 2019$155,000
+187.0%
74,248
+390.2%
0.00%
Q1 2019$54,000
+12.5%
15,145
+20.5%
0.00%
Q4 2018$48,000
-63.1%
12,565
-8.7%
0.00%
Q3 2018$130,000
-88.3%
13,769
-91.0%
0.00%
Q2 2018$1,115,000
+48.5%
152,592
+1.6%
0.00%
Q1 2018$751,000
+104.1%
150,132
+106.2%
0.00%
Q4 2017$368,000
-21.7%
72,801
-3.9%
0.00%
Q3 2017$470,000
+79.4%
75,741
+4.0%
0.00%
Q2 2017$262,000
+10.5%
72,8000.0%0.00%
Q1 2017$237,00072,800
+7279900.0%
0.00%
Q3 2015$010.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q2 2022
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 340,000$1,459,0000.53%
RTW INVESTMENTS, LP 4,733,323$20,306,0000.31%
APIS CAPITAL ADVISORS, LLC 70,000$300,0000.29%
Hudson Bay Capital Management LP 1,800,000$7,722,0000.10%
COWEN AND COMPANY, LLC 249,215$1,069,0000.05%
Kerrisdale Advisers, LLC 100,000$429,0000.05%
Woodline Partners LP 496,172$2,129,0000.04%
Shay Capital LLC 60,000$257,0000.03%
Walleye Capital LLC 231,037$991,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 212,700$912,0000.02%
View complete list of ARBUTUS BIOPHARMA CORP shareholders